PMC:7784830 / 8562-8752 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"164","span":{"begin":162,"end":174},"obj":"Species"},{"id":"165","span":{"begin":175,"end":183},"obj":"Species"}],"attributes":[{"id":"A164","pred":"tao:has_database_id","subj":"164","obj":"Tax:11118"},{"id":"A165","pred":"tao:has_database_id","subj":"165","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Roivant Sciences Gimsilumab – monoclonal antibody targets pro-inflammatory cytokine ‘granulocyte macrophage-colony stimulating factor (GM-CSF)’ which is high in corona virus patients. [48]"}

{"project":"LitCovid-sentences","denotations":[{"id":"T74","span":{"begin":0,"end":190},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Roivant Sciences Gimsilumab – monoclonal antibody targets pro-inflammatory cytokine ‘granulocyte macrophage-colony stimulating factor (GM-CSF)’ which is high in corona virus patients. [48]"}